Skip to main content
  1. Ruđer Bošković Institute
  2. News

News

Stories about research, events, people and innovations.

Advanced search

CLEAR ALL FILTERS
Category
Department or center
Year
632 results

Donation from the Terry Fox Run presented to the Ruđer Bošković Institute

Feb 10th 2026

As part of the Terry Fox Run charity race held last autumn at Jarun in Zagreb, €15,000 was raised and presented to the Ruđer Bošković Institute to support research into new prognostic biomarkers and therapeutic targets for lobular breast cancer.

What happens at the moment of collision? Scientists show for the first time how impacts in a mill trigger chemical reactions

Feb 6th 2026

Mechanochemistry, which drives chemical reactions by mechanical force, is increasingly used in materials synthesis and in sustainable “green” chemistry. It is carried out in an apparently simple way, by ball milling. Yet the most important part, what happens at the very moment when the balls collide with the particles, has remained beyond the reach of direct observation. A new study by an international team from the Ruđer Bošković Institute (RBI) and Friedrich-Alexander University Erlangen–Nürnberg now provides an answer to that question, at the molecular level.

Zagreb hosts Europe’s fusion elite, tackling a key bottleneck in today’s most ambitious energy endeavour

Feb 3rd 2026

This week, Zagreb is at the centre of the European debate on one of fusion energy’s most demanding challenges, how to efficiently manage heat and particle exhaust in future fusion power plants.

Croatia leads the region in a strategic EU project to protect the sea and water, and to drive innovation

Jan 30th 2026

Croatia has become the regional hub of the European EIT Water Knowledge and Innovation Community, one of the European Union’s largest projects for protecting the sea and water, and developing the blue economy, as highlighted today at an event held at the University of Zadar. 

Croatian scientists have identified what triggered the major Adriatic Sea mucilage event in 2024

Jan 23rd 2026

A collaboration between scientists from the Ruđer Bošković Institute’s Center for Marine Research and the Croatian company SeaCras has brought new insights into the Adriatic Sea mucilage phenomenon, which raised concern among residents and tourists in the middle of the peak season. The study was published in a leading scientific journal.

RBI secures €338,000 to strengthen its accelerator centre under the DIGIT project

Jan 23rd 2026

The Ruđer Bošković Institute (RBI) is among 13 Croatian public scientific institutions awarded non-repayable grants under the Professionalization of Research Centers call. RBI has been granted €338,486.62 for the project Optimization of operation and use of the RBI Tandem Accelerator Research Infrastructure (OTARI).

Satellite DNA — the genome’s overlooked infrastructure

Jan 21st 2026

A team of molecular biologists from the Ruđer Bošković Institute (RBI), from the Laboratory for Non-coding DNA, has published a scientific paper showing how dynamic changes in so-called satellite DNA sequences can significantly shape genomes and contribute to differences between very closely related organisms.

IRB develops hands-on machine learning exercises and a co-design framework for digital services within the SUSA project

Jan 19th 2026

The pan-European SUSA project (Sustainable Healthcare with Digital Health Data Competence) has launched one of the most ambitious educational initiatives aimed at closing the digital skills gap in Europe’s healthcare sector.

dm & IRB Mark a Decade of Support for Prostate Cancer Research

Jan 13th 2026

On Tuesday, January 13, the drugstore chain dm donated €17,290 to the Ruđer Bošković Institute (RBI). the funds are earmarked for a research project aimed at developing innovative therapies to make prostate cancer more vulnerable and less life-threatening.

New chemical compounds developed in the lab “target” a key protein switch that drives cancer growth

Dec 19th 2025

An international team of scientists has developed and tested, under laboratory conditions, nine new small molecules that could one day serve as the basis for new drugs against tumors linked to the BRAF V600E genetic mutation.